The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humans
Abstract
The pharmacokinetics of lamotrigine, a new anticonvulsant, were studied in three studies in normal volunteers. In the first study, five subjects received oral doses of lamotrigine up to 240 mg. A linear relationship was observed between dose administration and both peak drug concentration and AUC. In a second study 10 subjects received 120 mg lamotrigine and the mean (+/- SD) of the elimination half-life (t1/2) was 24.1 +/- 5.7 hours and of volume of distribution/bioavailability 1.2 +/- 0.12 L/kg. Saliva concentrations were 46% of the plasma concentration. Total urinary recovery of drug over 144 hours was 70.5% of the oral dose. A glucuronide conjugate accounted for 89.4% of the urinary recovery. In a third study the kinetics of repeated administration were studied. Fifteen subjects were randomized to lamotrigine (n = 10) or placebo (n = 5) and received multiple doses over 7 days. The overall plasma elimination t1/2 calculated from data during the 7 days was 25.5 +/- 10.2 hours. Observed pharmacokinetics on multiple administration obeyed closely those predicted from the single-dose experiment, suggesting the absence of autoinduction of metabolism. No clinically important side effects or changes in central nervous system or cardiovascular system variables, hematology, biochemistry, or urinalysis occurred during the 7 days.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenblatt (1982) · doi:10.1056/nejm198205063061804 · Cited by 584
Leach, M. J., Marden, C. M., & Miller, A. A. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03573.x · Cited by 549
Miller, A. A., Wheatley, P., Sawyer, D. A., Baxter, M. G., & Roth, B. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03572.x · Cited by 182
Lorazepam kinetics in the elderly
Greenblatt, D. J., ALLEN, M. D., Locniskar, A., Harmatz, J. S., & Shader, R. I. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979261103 · Cited by 153
Cohen, A., Ashby, L., Crowley, D., Land, G., Peck, A., & Miller, A. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb05120.x · Cited by 141
Self-citation
Cited by
Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy
Smith, D., Baker, G., Davies, G., Dewey, M., & Chadwick, D. W. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02417.x · Cited by 330
Lamotrigine: A Review of its Pharmacological Properties and Clinical Efficacy in Epilepsy
Goa, K. L., Ross, S. R., & Chrisp, P. (1993) · Drugs · doi:10.2165/00003495-199346010-00009 · Cited by 307
Mechanisms influencing stimulus-response properties of the human corticospinal system
Boroojerdi, B., Battaglia, F., Muellbacher, W., & Cohen, L. G. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00523-5 · Cited by 256
Sodium valproate acutely inhibits lamotrigine metabolism.
Yuen, A., Land, G., Weatherley, B., & Peck, A. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04079.x · Cited by 252
Self-citationChildren versus adults: pharmacokinetic and adverse-effect differences
Anderson, G. D. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.3.5.x · Cited by 187
Metadata
- Authors
- Cohen, A. F., Land, G. S., Breimer, D. D., Yuen, W. C., Winton, C., & Peck, A. W.
- Venue
- Clinical Pharmacology and Therapeutics
- Publisher
- Wiley
- Published
- 1987-11
- Volume
- 42
- Issue
- 5
- Pages
- 535-541
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2010356902
- Cited by
- 277
- References
- 5
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humans. https://app.cochat.ai/papers/10.1038/clpt.1987.193
- The paper
- Cohen, A. F., Land, G. S., Breimer, D. D., Yuen, W. C., Winton, C., & Peck, A. W. (1987). Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humans. Clinical Pharmacology and Therapeutics. https://doi.org/10.1038/clpt.1987.193
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.